Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil

Table 2 Serological prevalence for Toxoplasma gondii infection in leprosy patients, contacts and healthy controls

Individuals	Classification		n	Positive IgG anti-T.gondii, n (%)	Negative IgG anti-T.gondii, n (%)
	WHO	Madrid	n
Patients	PB	Indeterminate	15	11 (73.3%)	4 (26.7%)
	PB	Tuberculoid	48	34 (70.8%)	14 (29.2%)
	MB	Dimorph	66	51 (77.3%)	15 (22.7%)
	MB	Lepromatous	70	62 (88.6%)	8 (11.4%)
			199	158 (79.4%)	41 (20.6%)
Controls			52	16 (30.8%)	36 (69.2%)
Contacts			40	24 (60.0%)	16 (40.0%)
Total			291	218 (74.9%)	73 (25.1%)

ISSN: 2049-9957